Skip to Content

Complete the online application form no later than Friday, June 30, 2017.
NO EXTENSIONS WILL BE GRANTED.

An e-mail response will be sent confirming receipt.

* Fields marked with an asterisk are required.

Basic Information

Institution

Institution

Program

Program

Department

Department



Format 9995551111 for North American Users

Are you:

Are you

Are you Details

Please Specify

AllerGen trainees, are you a:

AllerGen trainees, are you a:

If a trainee or Allied Health Professional: do you want to enter the Abstract Competition?

If a trainee or Allied Health Professional: do you want to enter the Abstract Competition?

If a trainee or Allied Health Professional: do you want to enter the Abstract Competition?

If a trainee or Allied Health Professional: do you want to enter the Abstract Competition?

Participate in the optional two-minute oral presentation

Participate in the optional two-minute oral presentation

Participate in the optional two-minute oral presentation

Participate in the optional two-minute oral presentation

NOTE: AllerGen trainees must participate

Abstract Information

Abstract Title

Upload Abstract

Upload Abstract

Please choose the category you think most appropriately reflects your abstract content

Please choose the category you think most appropriately reflects your abstract content (please note this may be subject to change following review by the Abstract Committee Chairs):

Abstract Category
Abstract Category
  • Details
  • Details
  • Details
  • Details
  • Details
  • Details

Other Allergy/Immunology Details

Please Specify

The work outlined in this abstract has/has not been published elsewhere prior to
June 24, 2016

The work outlined in this abstract has/has not been published elsewhere prior to
June 24, 2016

The work outlined in this abstract has/has not been published elsewhere prior to June 24, 2016

The work outlined in this abstract has/has not been published elsewhere prior to June 24, 2016

Citation

If the abstract has been published or accepted to publication elsewhere (prior to the submission deadline of june 24, 2016, you will be required to provide the following information:

Date

Date

Comments

Comments

The work outlined in this abstract has/has not been accepted prior to June 24, 2016

The work outlined in this abstract has/has not been accepted prior to June 24, 2016 for future publication.

The work outlined in this abstract has/has not been accepted prior to June 24, 2016 for future publication.

The work outlined in this abstract has/has not been accepted prior to June 24, 2016 for future publication.

Citation

If the abstract has been published or accepted to publication elsewhere (prior to the submission deadline of june 24, 2016, you will be required to provide the following information:

Date

Date

Comments

Comments

Disclosure Information (for Conflict of Interest)

Disclosure should include any relationship that may bias your presentation or that, if known, could convey the perception of bias. The intent of this disclosure is not to prevent an abstract presenter from making a presentation. This policy allows the meeting participants to be fully knowledgeable in evaluating the information being presented. If the first (presenting) author feels that such a relationship exists, click 'Yes' so a notation may be made in the program with the nature of the relationship and the associated commercial or other entity. After answering 'Yes,' please indicate in the spaces provided, the name(s) and relationship(s) for each entity you list.

Disclosure Information (for Conflict of Interest)

Disclosure Information (for Conflict of Interest)

Terms and Conditions

  • Details
  • Details
  • Details
  • Details
  • Details
  • I understand that if accepted, this abstract becomes the property of the CSACI. Ownership of submitted abstract not accepted for presentation reverts to the authors.
  • I affirm that the abstract submitted has not been and will not be published as an article on or before June 24, 2016 (unless otherwise disclosed above)
  • On behalf of all authors of this abstract, and to the best of my knowledge, I affirm that all information in this abstract is reported as accurately as possible.
  • I understand that the CSACI has a policy on the discussion of unlabeled uses of Health Canada regulated products. This policy requires me to disclose to the audience at the time of presentation any references to such unlabeled uses. I agree to do so in any presentation resulting from the submission of this abstract.
  • I affirm that I have read and understood the Abstract Guidelines document.

Add Conflict of Interest


* Fields marked with an asterisk are required.

working ...
x


please wait . . . loading